© 2003 by European Society of Cardiology
Home monitoring in ICD therapy: future perspectives
Department of Cardiology, Thoraxcenter Erasmus MC, Rotterdam, The Netherlands
The expanding indications for ICD therapy and the complexity of current devices will have impact on follow-up policy. The application of ICD therapy requires elaborate attention to technical aspects, arrhythmias, and the clinical course of the underlying disease. Currently, the quality of medical supervision is dependent on scheduled regular follow-up visits. A disadvantage of long intervals can be a delay in the physician's or patient's awareness of changes in the clinical status. Some patients will need more intensive follow-up while others will have the device as a stand-by and only need technical follow-up. A possibility to address this situation, is the transmission of data, already stored in the implanted device. This will guarantee continuous patient surveillance and could possibly help to avoid unnecessary follow-up visits.
Key Words: Home monitoring, ICD, arrhythmias
Correspondence: D. A. M. J. Theuns, M.Sc., Erasmus MC, Department of Electrophysiology, Bd402, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Tel: +31-10-4633991; Fax: +31-10-4634420; E-mail: d.a.m.j.theuns{at}erasmusmc.nl
[1] Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933–1940.
[2] A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997; 337: 1576–1583.
[3] Buxton A, Lee K, Fisher J, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999; 341: 1882–1890.
[4] Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–883.
[5] Schoels W, Swerdlow CD, Jung W, Stein KM, Seidl K, Haffajee CJ. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system. J Cardiovasc Electrophysiol 2001; 12: 521–528.[CrossRef][Web of Science][Medline]
[6] Kühlkamp V. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 2002; 39: 790–797.
[7] Jordaens L, Olsson O, Van de Bruaene F, Fiers T. Implantable cardioverter defibrillator: data storage and retrieval with Patientlog. Pacing Clin Electrophysiol 1991; 14: 317–321.[Medline]
[8] Sarter BH, Callans DJ, Gottlieb GD, Schwartzman DS, Marchlinski FE. Implantable defibrillator diagnostic storage capabilities: evolution, current status, and future utilization. Pacing Clin Electrophysiol 1998; 21: 1287–1298.[Medline]
[9] Gregoratos G, Cheitlin A, Epstein AE, et al. ACC/AHA Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. J Am Coll Cardiol 1998; 31: 1175–1209.
[10] Hauer RN, Aliot E, Block M, et al. Indications for implantable cardioverter defibrillator (ICD) therapy. Europace 2001; 3: 169–176.
[11] Furman S and Escher DJW. Transtelephone pacemaker monitoring. In Schaldach M and Furman S (Eds.). Advances in Pacemaker Technology 1975; Berlin Springer pp. 177–194.
[12] Griffin JC, Schuenemeyer TD, Hess KR. Pacemaker follow-up: Its role in the detection and correction of pacemaker system malfunction. Pacing Clin Electrophysiol 1986; 9: 387–391.[Medline]
[13] Vallario LE, Leman RB, Gillette PC. Pacemaker follow-up and adequacy of Medicare guidelines. Am Heart J 1988; 116: 11–15.[CrossRef][Web of Science][Medline]
[14] Gessman LJ, Vielbig RE, Waspe LE, Moss L, Damm D, Sundeen F. Accuracy and clinical utility of transtelephonic pacemaker follow-up. Pacing Clin Electrophysiol 1995; 18: 1032–1034.[Medline]
[15] Igidbashian D, Stellbrink C, Hartmann A, Gill JS, Wunderlich E, Santini M. Benefit of permanent pacemaker follow-up with home monitoring (abstract). Pacing Clin Electrophysiol 2002; 24: 534.
[16] Dressing TJ, Schott R, McDowell C, et al. Transtelephonic ICD follow-up is better: more comprehensive, less intrusive and more desirable (abstract). Pacing Clin Electrophysiol 2002; 24: 577.
[17] Chan AQ and Chun S. Cost effectiveness of wireless home monitoring pacemaker compared to conventional pacemaker (abstract). Pacing Clin Electrophysiol 2002; 24: 534.
[18] Greene M, Newman D, Geist M, Paquette M, Heng P, Dorian P. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace 2000; 2: 263–269.
[19] Grom A, Baron TW, Faber TS, Brunner M, Bode C, Zehender M. Clusters of life-threatening ventricular arrhythmias in patients with implanted cardioverter-defibrillators: prevalence, characteristics, and risk stratification. Clin Cardiol 2001; 24: 330–333.[Web of Science][Medline]
[20] Cleland JG. From left ventricular dysfunction to heart failure. Arch Mal Coeur Vaiss 1996; 89: 1397–1402.[Medline]
[21] Khand AU, Gemmell I, Rankin AC, Cleland JGF. Clinical events leading to the progression of heart failure: Insights from a national database of hospital discharges. Eur Heart J 2001; 22: 153–164.
[22] Gronefeld GC, Mauss O, Li YG, Klingenheben T, Hohnloser SH. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study. J Cardiovasc Electrophysiol 2000; 11: 1208–1214.[CrossRef][Web of Science][Medline]
[23] Grimm W, Flores BF, Marchlinski FE. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1992; 15: 1667–1673.[CrossRef][Medline]
[24] Kühlkamp V, Dörnberger V, Mewis C, Suchalla R, Bosch R, Seipel L. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol 1999; 10: 905–915.[Web of Science][Medline]
[25] Theuns DAMJ, Klootwijk APJ, Kimman GP, Simmoons ML, Roelandt JRTC, Jordaens LJLM. Clinical benefit, survival, and adverse events in patients with an implantable cardioverter defibrillator: The initial Rotterdam experience. Netherlands Heart J 2001; 9: 216–221.
[26] Theuns D, Klootwijk AP, Kimman GP, Szili-Torok T, Roelandt JR, Jordaens L. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators. Europace 2001; 3: 181–186.
[27] Pinski S and Fahy G. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 1995; 92: 1651–1664.
[28] Hauser RG, Hayes DL, Almquist AK, et al. Unexpected ICD pulse generator failure due to electronic circuit damage caused by electrical overstress. Pacing Clin Electrophysiol 2001; 24: 1046–1054.[CrossRef][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. E. Marine Remote monitoring for prevention of inappropriate implantable cardioverter defibrillator shocks: is there no place like home? Europace, April 1, 2009; 11(4): 409 - 411. [Full Text] [PDF]
|
|
|
|
|
|
M.J. P. Raatikainen, P. Uusimaa, M. M.E. van Ginneken, J. P.G. Janssen, and M. Linnaluoto Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up Europace, October 1, 2008; 10(10): 1145 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Masella, P. Zanaboni, F. Di Stasi, S. Gilardi, P. Ponzi, and S. Valsecchi Assessment of a remote monitoring system for implantable cardioverter defibrillators J Telemed Telecare, September 1, 2008; 14(6): 290 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Nielsen, H. Kottkamp, M. Zabel, E. Aliot, U. Kreutzer, A. Bauer, A. Schuchert, H. Neuser, B. Schumacher, H. Schmidinger, et al. Automatic home monitoring of implantable cardioverter defibrillators Europace, June 1, 2008; 10(6): 729 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Heidbuchel, P. Lioen, S. Foulon, W. Huybrechts, J. Ector, R. Willems, and H. Ector Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator Europace, March 1, 2008; 10(3): 351 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Siaplaouras, A. Buob, H. R. Neuberger, and C. Mewis Remote detection of incessant slow VT with an ICD capable of home monitoring Europace, July 1, 2006; 8(7): 512 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Perings, G. Klein, E. Toft, C. Moro, D. Klug, D. Bocker, H.J. Trappe, T. Korte, and on behalf of the RIONI Investigators The RIONI study rationale and design: validation of the first stored electrograms transmitted via home monitoring in patients with implantable defibrillators. Europace, April 1, 2006; 8(4): 288 - 292. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||